T1	Participants 80 113	subjects with cardiovascular risk
T2	Participants 441 503	two groups of middle-aged men differing in cardiovascular risk
T3	Participants 505 580	46 survivors of myocardial infarction before age 50 and 60 healthy controls
T4	Participants 676 713	Twenty-eight patients and 58 controls
T5	Participants 1298 1335	subjects with the TT variant genotype
T6	Participants 1412 1448	subjects with low folate (P = 0.012)
T7	Participants 1457 1478	placebo control group
T8	Participants 1601 1619	supplemented group
T9	Participants 1857 1903	subjects with normal folate levels (P = 0.015)
T10	Participants 1908 1939	subjects with low folate levels
